Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method.
Compounds from 16 classes of antimicrobial drugs were tested for their abilities to inhibit the in vitro multiplication of nanobacteria (NB), a newly discovered infectious agent found in human kidney stones and kidney cyst fluids from patients with polycystic kidney disease (PKD). Because NB form surface calcifications at physiologic levels of calcium and phosphate, they have been hypothesized to mediate the formation of tissue calcifications. We describe a modified microdilution inhibitory test that accommodates the unique growth conditions and long multiplication times of NB. This modified microdilution method included inoculation of 96-well plates and determination of inhibition by periodic measurement of the absorbance for 14 days in cell culture medium under cell culture conditions. Bactericidal or bacteriostatic drug effects were distinguished by subsequent subculture in drug-free media and monitoring for increasing absorbance. NB isolated from fetal bovine serum (FBS) were inhibited by tetracycline HCl, nitrofurantoin, trimethoprim, trimethoprim-sulfamethoxazole, and ampicillin at levels achievable in serum and urine; all drugs except ampicillin were cidal. Tetracycline also inhibited multiplication of isolates of NB from human kidney stones and kidney cyst fluids from patients with PKD. The other antibiotics tested against FBS-derived NB either had no effect or exhibited an inhibitory concentration above clinically achievable levels; the aminoglycosides and vancomycin were bacteriostatic. Antibiotic-induced morphological changes to NB were observed by electron microscopy. Bisphosphonates, aminocaproic acid, potassium citrate-citric acid solutions, and 5-fluorouracil also inhibited the multiplication of NB in a cidal manner. Insights into the nature of NB, the action(s) of these drugs, and the role of NB in calcifying diseases may be gained by exploiting this in vitro inhibition test system.
Cíftçíoglu
N
N
Department of Biochemistry, University of Kuopio, FIN-70211, Kuopio, Finland.
Miller-Hjelle
M A
MA
Hjelle
J T
JT
Kajander
E O
EO
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000648:ultrastructure; D004164:Diphosphonates / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D007669:Kidney Calculi / Q000382:microbiology*; D008826:Microbial Sensitivity Tests / Q000379:methods*; D008854:Microscopy, Electron; D007690:Polycystic Kidney Diseases / Q000382:microbiology*; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D004164:Diphosphonates; D013752:Tetracycline; D005472:Fluorouracil